PELP1 and breast cancer: The PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases has been shown to drive therapy resistant ER + BC [49] and cytoplasmic PELP1/SRC-3 signaling complexes increase BC stem cells [50].